Skip to main content

ResearchHubLoading navigation…

Loading ResearchHub…

Explore the network

Research, people, journals and institutions — all in one place.

Explore

01Research 02Smart search 03Researchers 04Journals 05Institutions 06RHR Rankings 07ResearchHub platform 08Events

Work together

Turn ideas into projects, questions and reusable datasets.

Connect

01Projects 02Questions 03Datasets

Stay informed

Follow trends, opportunities and your research library.

Insights

01Research trends 02Opportunities 03Library 04Research services 05ResearchHub Pro 06Pricing

ResearchHub

Explore ResearchHub.

Personal

01Recommended research 02Research intelligence

Home Search Network Library Log in

ResearchHub

Research, connected

Explore the graph

ResearchGate

Download ResearchHub

GET IT ONGoogle PlayComing soonDownload on theApp StoreComing soonEXPLORE IT ONAppGalleryComing soon

Research

Research Researchers Journals Institutions RHR Rankings

Contribute

Projects Questions Datasets Opportunities

Platform

ResearchHub platform About Blog Community Help API Licensing

Shopping

Contact and support

Need help, have a question, or want to contact the ResearchHub team?

Contact and support support@aresearch.uk

© 2026 ResearchHub. Built for responsible scholarly connection.

Help Article feed Privacy Terms Cookies This work is licensed under Creative Commons Attribution 4.0 InternationalCC BY 4.0

Privacy-aware community infrastructure

Nature Reviews Drug Discovery - ResearchHub

Journal

Nature Reviews Drug Discovery

1474-1776 · Springer Science and Business Media LLC

21 verified public works

Browse all journals →

Probing the many benefits of GLP-1 receptor agonists

2026 · 0 citations

Gene therapy for rare lysosomal storage disorder nabs FDA approval

2026 · 0 citations

COPD trial wins spur broad respiratory hopes

2026 · 0 citations

Soft drugs: design principles and topical applications

2026 · 0 citations

The value of speed for drug developers

2026 · 0 citations

First myostatin-targeted antibody approved for spinal muscular atrophy

2026 · 0 citations

Upcoming FDA approval decisions in Q4 2026

2026 · 0 citations

Un-siloed biomedical opportunities

2026 · 0 citations

Newest glue degrader nabs multiple myeloma approval

2026 · 0 citations

Click chemistry platform enhances ADC tumour targeting

2026 · 0 citations

Serotonin receptor agonist suppresses colorectal cancer

2026 · 0 citations

A metabolically activated molecular glue

2026 · 0 citations

Viral protease-initiated pyroptosis

2026 · 0 citations

CAR-T cell therapy for multiple sclerosis

2026 · 0 citations

RevMed’s RAS inhibitor gains landmark FDA approval for pancreatic cancer

2026 · 0 citations

Small molecule boosts Parkinson disease treatment

2026 · 0 citations

Oncolytic virus nabs FDA approval

2026 · 0 citations

Orexin receptor agonist secures landmark narcolepsy approval

2026 · 0 citations

The changing face of UK academic drug screening in the past decade

2026 · 0 citations

Evolution of the psoriasis therapy landscape

2026 · 0 citations

Better data for better medicines: a path to data-driven medicines regulation

2026 · 0 citations

Page 1 of 1